Inhibiting Free Fatty Acid Transport to Improve CAR-T Cell Therapy of Relapsed B-Cell Acute Lymphoblastic Leukemia
Lecture date: August 13, 2026
Matthew Witkowski, PhD
Assistant Professor, University of Colorado Anschutz Medical Campus
Matt Witkowski is an Assistant Professor at the University of Colorado Anschutz Medical Campus whose research focuses on overcoming treatment resistance in high-risk B-cell acute lymphoblastic leukemia (B-ALL). His team aims to identify critical genetic and metabolic determinants driving B-ALL resistance to chemotherapy and chimeric antigen receptor-T cell therapy
